The Effectiveness of Local Consolidative Therapy for Advanced Lung Adenocarcinoma Harboring EGFR Mutation Treated With First-line Afatinib

被引：0
|
作者：
Tsai, Y. [1 ]
Tsai, M. [2 ]
Ma, J. [2 ]
Kuo, C. [2 ]
Yang, C. [2 ]
Wu, K. [2 ]
Lee, M. [2 ]
Lee, Y. [3 ]
Huang, C. [4 ]
Hung, J. [1 ]
Chong, I. [2 ]
机构：
[1] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Surg, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2728
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib
    Tsai, Ming-Ju
    Hung, Jen-Yu
    Ma, Juei-Yang
    Tsai, Yu-Chen
    Wu, Kuan-Li
    Lee, Mei-Hsuan
    Kuo, Chia-Yu
    Chuang, Cheng-Hao
    Lee, Tai-Huang
    Lee, Yen-Lung
    Huang, Chun-Ming
    Shen, Mei-Chiou
    Yang, Chih-Jen
    Chong, Inn-Wen
    CANCERS, 2023, 15 (07)
  • [2] Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
    Liang, Sheng-Kai
    Hsieh, Min-Shu
    Lee, Meng-Rui
    Keng, Li-Ta
    Ko, Jen-Chung
    Shih, Jin-Yuan
    ONCOTARGET, 2017, 8 (52) : 90430 - 90443
  • [3] Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review
    Koehler, Jens
    Schuler, Martin
    ONKOLOGIE, 2013, 36 (09): : 510 - 518
  • [4] Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs
    Xu, Qinghua
    Zhou, Fei
    Liu, Hui
    Jiang, Tao
    Li, Xuefei
    Xu, Yaping
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1383 - 1392
  • [5] Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib
    Wu, Jia-Jun
    Tseng, Jeng-Sen
    Zheng, Zhe-Rong
    Chu, Cheng-Hsiang
    Chen, Kun-Chieh
    Lin, Mong-Wei
    Huang, Yen-Hsiang
    Hsu, Kuo-Hsuan
    Yang, Tsung-Ying
    Yu, Sung-Liang
    Chen, Jin-Shing
    Ho, Chao-Chi
    Chang, Gee-Chen
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [6] Concurrent Chemotherapy and First-Generation EGFR-TKI as First-Line Treatment in Advanced Lung Adenocarcinoma Harboring EGFR Mutation
    Xu, Z.
    Hao, X.
    Lin, L.
    Li, J.
    Xing, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1111 - S1111
  • [7] Local Consolidative Radiation Prolongs Disease Control of Patients with Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated with First-Line EGFR-TKIs
    An, N.
    Wang, H.
    Jing, W.
    Zhu, H.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E494 - E495
  • [8] Afatinib in the first line therapy of EGFR mutation positive adenocarcinoma of lung: Single institute experience
    Ye, R-H.
    Wu, Y-Y.
    Huang, T-C.
    Chen, J-H.
    Dai, M-S.
    Ho, C-L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature
    Shi, Yuequan
    Wang, Mengzhao
    THORACIC CANCER, 2018, 9 (12) : 1788 - 1794
  • [10] Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring EGFR Mutations.
    Hu, F.
    Xu, J.
    Zhang, B.
    Li, C.
    Nie, W.
    Gu, P.
    Hu, P.
    Wang, H.
    Zhang, Y.
    Shen, Y.
    Wang, S.
    Han, B.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S337 - S337
12345